Using podocyte-specific Shroom3 knockout mice and transcriptomic approaches, we assessed SHROOM3 function in vivo and in vitro, focusing on Adriamycin (ADR)-induced nephropathy, a validated FSGS model characterized by progressive podocyte loss and glomerulosclerosis. This evidence concerns the gene SHROOM3 and glomerulosclerosis.